Editas Medicine logo
Editas Medicine EDIT
$ 1.63 -4.68%
report update icon

Quarterly report 2026-Q3
added 11-09-2026

Editas Medicine Market Cap | EDIT

As of November 22, 2026 Editas Medicine has a market cap of $ 145 M


Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap Editas Medicine

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
206 M 166 M 845 M 665 M 1.29 B 3.6 B 1.34 B 1 B 1.58 B 550 M - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
3.6 B 166 M 1.12 B

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Biotechnology industry

Issuer Market Cap Price % 24h Market Cap Country
Seer Seer
SEER
123 M $ 1.34 -3.25 % $ 74.5 M usaUSA
Gracell Biotechnologies Gracell Biotechnologies
GRCL
1.99 B - - $ 3.37 B chinaChina
Summit Therapeutics Summit Therapeutics
SMMT
12 B $ 9.94 -6.01 % $ 7.43 B britainBritain
Shattuck Labs Shattuck Labs
STTK
349 M $ 4.49 -1.43 % $ 312 M usaUSA
Silence Therapeutics plc Silence Therapeutics plc
SLN
812 M $ 19.81 0.08 % $ 2.81 B britainBritain
Soligenix Soligenix
SNGX
6.12 M $ 0.22 -8.25 % $ 1.14 M usaUSA
Sanofi Sanofi
SNY
59.3 B $ 46.51 0.97 % $ 56.8 B franceFrance
Spruce Biosciences Spruce Biosciences
SPRB
47.6 M $ 38.02 -6.11 % $ 29.1 M usaUSA
Spero Therapeutics Spero Therapeutics
SPRO
133 M $ 0.74 -10.95 % $ 41.5 M usaUSA
Sarepta Therapeutics Sarepta Therapeutics
SRPT
1.64 B $ 13.34 -5.86 % $ 1.34 B usaUSA
Savara Savara
SVRA
1.17 B $ 4.28 -17.95 % $ 952 M usaUSA
Teligent, Inc. Teligent, Inc.
TLGT
5.03 M - -13.85 % $ 16.1 M usaUSA
Viela Bio, Inc. Viela Bio, Inc.
VIE
427 M - - $ 2.91 B usaUSA
Sutro Biopharma Sutro Biopharma
STRO
181 M $ 8.6 -1.38 % $ 73.1 M usaUSA
Tarsus Pharmaceuticals Tarsus Pharmaceuticals
TARS
2.92 B $ 72.94 -6.09 % $ 3.05 B usaUSA
Supernus Pharmaceuticals Supernus Pharmaceuticals
SUPN
3.11 B $ 36.28 1.88 % $ 2.05 B usaUSA
TG Therapeutics TG Therapeutics
TGTX
4.34 B $ 63.39 -2.3 % $ 9.15 B usaUSA
Aphria Inc. Aphria Inc.
APHA
1.11 B - -0.45 % $ 4.87 B canadaCanada
Viridian Therapeutics Viridian Therapeutics
VRDN
2.99 B $ 29.91 -4.87 % $ 3.05 B usaUSA
Trevi Therapeutics Trevi Therapeutics
TRVI
1.51 B $ 13.35 -2.73 % $ 1.8 B usaUSA
Aerpio Pharmaceuticals, Inc. Aerpio Pharmaceuticals, Inc.
ARPO
63.6 M - -0.90 % $ 104 M usaUSA
Chiasma, Inc. Chiasma, Inc.
CHMA
207 M - -6.00 % $ 238 M usaUSA
vTv Therapeutics vTv Therapeutics
VTVT
67.6 M $ 16.0 -2.2 % $ 64.2 M usaUSA
Adamas Pharmaceuticals, Inc. Adamas Pharmaceuticals, Inc.
ADMS
164 M - - $ 376 M usaUSA
Cellect Biotechnology Ltd. Cellect Biotechnology Ltd.
APOP
485 M - 0.38 % $ 12.9 M israelIsrael
Xenon Pharmaceuticals Xenon Pharmaceuticals
XENE
2.38 B $ 36.89 -1.78 % $ 2.92 B canadaCanada
Xeris Pharmaceuticals Xeris Pharmaceuticals
XERS
967 M $ 16.95 2.02 % $ 2.72 B usaUSA
AzurRx BioPharma, Inc. AzurRx BioPharma, Inc.
AZRX
40.9 M - 2.07 % $ 34.4 M usaUSA
X4 Pharmaceuticals X4 Pharmaceuticals
XFOR
179 M $ 3.01 1.69 % $ 127 M usaUSA
Cerecor Inc. Cerecor Inc.
CERC
230 M - -1.68 % $ 283 M usaUSA
Constellation Pharmaceuticals, Inc. Constellation Pharmaceuticals, Inc.
CNST
1.57 B - - $ 1.63 B usaUSA
Auris Medical Holding Ltd. Auris Medical Holding Ltd.
EARS
8.29 M - -1.77 % $ 39.2 M bermudaBermuda
Dicerna Pharmaceuticals, Inc. Dicerna Pharmaceuticals, Inc.
DRNA
1.67 B - 0.34 % $ 2.98 B usaUSA
ERYTECH Pharma S.A. ERYTECH Pharma S.A.
ERYP
24.2 M - 1.3 % $ 27.7 M franceFrance
GW Pharmaceuticals plc GW Pharmaceuticals plc
GWPH
4.79 B - - $ 6.81 B britainBritain
22nd Century Group 22nd Century Group
XXII
541 K $ 0.32 -19.83 % $ 58.9 K usaUSA
Kadmon Holdings, Inc. Kadmon Holdings, Inc.
KDMN
813 M - - $ 1.7 B usaUSA
Liminal BioSciences Liminal BioSciences
LMNL
2.65 M - - $ 256 M canadaCanada
argenx SE argenx SE
ARGX
42.4 B $ 926.42 -1.66 % $ 56.8 B niderlandNiderland
Tonix Pharmaceuticals Holding Corp. Tonix Pharmaceuticals Holding Corp.
TNXP
114 M $ 2.33 -7.25 % $ 19.8 M usaUSA
Zai Lab Limited Zai Lab Limited
ZLAB
21.6 B $ 21.01 -4.16 % $ 23 B chinaChina
Neos Therapeutics, Inc. Neos Therapeutics, Inc.
NEOS
80.6 M - -2.54 % $ 57.2 M usaUSA
Zentalis Pharmaceuticals Zentalis Pharmaceuticals
ZNTL
192 M $ 1.37 0.74 % $ 98.5 M usaUSA
Zoetis Zoetis
ZTS
56.1 B $ 78.81 -2.47 % $ 34.9 B usaUSA
Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.
ODT
759 M - -3.18 % $ 58.5 M usaUSA
Orphazyme A/S Orphazyme A/S
ORPH
236 M - -2.25 % $ 31.3 M danmarkDanmark
Osmotica Pharmaceuticals plc Osmotica Pharmaceuticals plc
OSMT
262 M - -10.74 % $ 89.9 M usaUSA
Pandion Therapeutics, Inc. Pandion Therapeutics, Inc.
PAND
419 M - - $ 1.77 B usaUSA
Xenetic Biosciences Xenetic Biosciences
XBIO
4.37 M $ 1.47 -4.55 % $ 2.5 M usaUSA
Translate Bio, Inc. Translate Bio, Inc.
TBIO
1.23 B - - $ 2.81 B usaUSA